YAP Inactivation in Estrogen Receptor Alpha-Positive Hepatocellular Carcinoma with Less Aggressive Behavior

0
150
The authors evaluated the expression of estrogen receptor alpha and its association with clinicopathological features in 339 hepatocellular carcinoma patients.
[Experimental & Molecular Medicine]
Jeon, Y., Yoo, J. E., Rhee, H., Kim, Y.-J., Il Kim, G., Chung, T., Yoon, S., Shin, B., Woo, H. G., & Park, Y. N. (2021). YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behavior. Experimental & Molecular Medicine, 1–13. https://doi.org/10.1038/s12276-021-00639-2 Cite
Full Article